Source: ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Jordi Solé-Violán, Elisa Hernández-Brito, José Manuel Valencia-Gallardo, Estefanía Herrera-Ramos, Luis Borderías, M. Luisa Briones, Olga Rajas, Jorge Freixinet, Leonardo Lorente, Antoni Payeras, José Ferreres, Nieves Carbonell, Nereida González-Quevedo, Jesús M. González-Martín, Felipe Rodríguez de Castro, Carlos Rodríguez-Gallego. Challenges in understanding host genetics and severity of community-acquired pneumonia. ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: 1254-1262 Year: 2002 Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis Source: International Congress 2018 – Microorganisms and lung ecology: living in peace with bugs Year: 2018 Severe community-acquired pneumonia in China: epidemiology and clinical practice Source: International Congress 2019 – Chinese programme 2019: Part II Year: 2019 Update on therapeutic strategies in community-acquired pneumonia    Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Source: Milan 2017 - Educational material Year: 2017 The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 The peculiarity of etiological agents of community-acquired pneumonia depends on the severity Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups Source: Eur Respir J 2013; 41: 917-922 Year: 2013 Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020 The pathophysiology of pneumococcal pneumonia Source: Eur Respir Monogr 2014; 63: 42-63 Year: 2014 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2011; 39: 7-8 Year: 2012 Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect Source: Eur Respir J 2012; 39: 7-8 Year: 2012 Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017